|
1
|
Rogers HW, Weinstock MA, Harris AR,
Hinckley MR, Feldman SR, Fleischer AB, Fleischer AB and Coldiron
BM: Incidence estimate of non-melanoma skin cancer in the United
States, 2006. Arch Dermatol. 146:283–287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eisemann N, Waldmann A, Geller AC,
Weinstock MA, Volkmer B, Greinert R, Breitbart EW and Katalinic A:
Non-melanoma skin cancer incidence and impact of skin cancer
screening on incidence. J Invest Dermatol. 134:43–50. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Narayanan DL, Saladi RN and Fox JL:
Ultraviolet radiation and skin cancer. Int J Dermatol. 49:978–986.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Veness MJ: Defining patients with
high-risk cutaneous squamous cell carcinoma. Australas J Dermatol.
47:28–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Echarri MJ, Lopez-Martin A and Hitt R:
Targeted therapy in locally advanced and Recurrent/metastatic head
and neck squamous cell carcinoma (LA-R/M HNSCC). Cancers (Basel).
8:E272016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshihara N, Takagi A, Ueno T and Ikeda S:
Inverse correlation between microtubule-associated protein
1A/1B-light chain 3 and p62/sequestosome-1 expression in the
progression of cutaneous squamous cell carcinoma. J Dermatol.
41:311–315. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okura R and Nakamura M: Overexpression of
autophagy-related beclin-1 in cutaneous squamous cell carcinoma
with lymph-node metastasis. Eur J Dermatol. 21:1002–1003.
2011.PubMed/NCBI
|
|
8
|
Klionsky DJ: Autophagy: From phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rabinowitz JD and White E: Autophagy and
metabolism. Science. 330:1344–1348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Levine B and Klionsky DJ: Development by
self-digestion: Molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin S and White E: Role of autophagy in
cancer: Management of metabolic stress. Autophagy. 3:28–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lorin S, Hamai A, Mehrpour M and Codogno
P: Autophagy regulation and its role in cancer. Semin Cancer Biol.
23:361–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu JL, Chen FF, Lung J, Lo CH, Lee FH, Lu
YC and Hung CH: Prognostic significance of p62/SQSTM1 subcellular
localization and LC3B in oral squamous cell carcinoma. Br J Cancer.
111:944–954. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Claerhout S, Verschooten L, Van Kelst S,
De Vos R, Proby C, Agostinis P and Garmyn M: Concomitant inhibition
of AKT and autophagy is required for efficient cisplatin-induced
apoptosis of metastatic skin carcinoma. Int J Cancer.
127:2790–2803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wright TJ, McKee C, Birch-Machin MA, Ellis
R, Armstrong JL and Lovat PE: Increasing the therapeutic efficacy
of docetaxel for cutaneous squamous cell carcinoma through the
combined inhibition of phosphatidylinositol 3-kinase/AKT signalling
and autophagy. Clin Exp Dermatol. 38:421–423. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan TF, Bu LL, Wang WM, Ma SR, Liu JF,
Deng WW, Mao L, Yu GT, Huang CF, Liu B, et al: Tumor growth
suppression by inhibiting both autophagy and STAT3 signaling in
HNSCC. Oncotarget. 6:43581–43593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barrette K, Van Kelst S, Wouters J,
Marasigan V, Fieuws S, Agostinis P, van den Oord J and Garmyn M:
Epithelial-mesenchymal transition during invasion of cutaneous
squamous cell carcinoma is paralleled by AKT activation. Br J
Dermatol. 171:1014–1021. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi SR, Chung BY, Kim SW, Kim CD, Yun WJ,
Lee MW, Choi JH and Chang SE: Activation of autophagic pathways is
related to growth inhibition and senescence in cutaneous squamous
cell carcinoma. Exp Dermatol. 23:718–724. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balamucki CJ, Mancuso AA, Amdur RJ, Kirwan
JM, Morris CG, Flowers FP, Stoer CB, Cognetta AB and Mendenhall WM:
Skin carcinoma of the head and neck with perineural invasion. Am J
Otolaryngol. 33:447–454. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Warren TA, Panizza B, Porceddu SV, Gandhi
M, Patel P, Wood M, Nagle CM and Redmond M: Outcomes after surgery
and postoperative radiotherapy for perineural spread of head and
neck cutaneous squamous cell carcinoma. Head Neck. 38:824–831.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Warren TA, Broit N, Simmons JL, Pierce CJ,
Chawla S, Lambie DL, Quagliotto G, Brown IS, Parsons PG, Panizza BJ
and Boyle GM: Expression profiling of cutaneous squamous cell
carcinoma with perineural invasion implicates the p53 pathway in
the process. Sci Rep. 6:340812016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Padilla RS, Sebastian S, Jiang Z, Nindl I
and Larson R: Gene expression patterns of normal human skin,
actinic keratosis, and squamous cell carcinoma: A spectrum of
disease progression. Arch Dermatol. 146:288–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ra SH, Li X and Binder S: Molecular
discrimination of cutaneous squamous cell carcinoma from actinic
keratosis and normal skin. Mod Pathol. 24:963–973. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mitsui H, Suárez-Farinas M, Gulati N, Shah
KR, Cannizzaro MV, Coats I, Felsen D, Krueger JG and Carucci JA:
Gene expression profiling of the leading edge of cutaneous squamous
cell carcinoma: IL-24-driven MMP-7. J Invest Dermatol.
134:1418–1427. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Farshchian M, Nissinen L, Siljamäki E,
Riihilä P, Toriseva M, Kivisaari A, Ala-Aho R, Kallajoki M,
Veräjänkorva E, Honkanen HK, et al: EphB2 promotes progression of
cutaneous squamous cell carcinoma. J Invest Dermatol.
135:1882–1892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jian Q, Miao Y, Tang L, Huang M, Yang Y,
Ba W, Liu Y, Chi S and Li C: Rab23 promotes squamous cell carcinoma
cell migration and invasion via integrin β1/Rac1 pathway.
Oncotarget. 7:5342–5352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Turei D, Földvari-Nagy L, Fazekas D, Módos
D, Kubisch J, Kadlecsik T, Demeter A, Lenti K, Csermely P, Vellai T
and Korcsmáros T: Autophagy regulatory network-a systems-level
bioinformatics resource for studying the mechanism and regulation
of autophagy. Autophagy. 11:155–165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
de Hoon MJ, Imoto S, Nolan J and Miyano S:
Open source clustering software. Bioinformatics. 20:1453–1454.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saldanha AJ: Java Treeview-extensible
visualization of microarray data. Bioinformatics. 20:3246–3248.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Parikh SA, Patel VA and Ratner D: Advances
in the management of cutaneous squamous cell carcinoma. F1000Prime
Rep. 6:702014. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miller SJ: Defining, treating, and
studying very high-risk cutaneous squamous cell carcinomas. Arch
Dermatol. 146:1292–1295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ross AS, Whalen FM, Elenitsas R, Xu X,
Troxel AB and Schmults CD: Diameter of involved nerves predicts
outcomes in cutaneous squamous cell carcinoma with perineural
invasion: an investigator-blinded retrospective cohort study.
Dermatol Surg. 35:1859–1866. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nindl I, Dang C, Forschner T, Kuban RJ,
Meyer T, Sterry W and Stockfleth E: Identification of
differentially expressed genes in cutaneous squamous cell carcinoma
by microarray expression profiling. Mol Cancer. 5:302006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rothenberg SM and Ellisen LW: The
molecular pathogenesis of head and neck squamous cell carcinoma. J
Clin Invest. 122:1951–1957. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gu Y, Li P, Peng F, Zhang M, Zhang Y,
Liang H, Zhao W, Qi L, Wang H, Wang C and Guo Z: Autophagy-related
prognostic signature for breast cancer. Mol Carcinog. 55:292–299.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim KW, Mutter RW, Cao C, Albert JM,
Freeman M, Hallahan DE and Lu B: Autophagy for cancer therapy
through inhibition of pro-apoptotic proteins and mammalian target
of rapamycin signaling. J Biol Chem. 281:36883–36890. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
O Farrell F, Rusten TE and Stenmark H:
Phosphoinositide 3-kinases as accelerators and brakes of autophagy.
FEBS J. 280:6322–6337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cerniglia GJ, Karar J, Tyagi S,
Christofidou-Solomidou M, Rengan R, Koumenis C and Maity A:
Inhibition of autophagy as a strategy to augment radiosensitization
by the dual phosphatidylinositol 3-kinase/mammalian target of
rapamycin inhibitor NVP-BEZ235. Mol Pharmacol. 82:1230–1240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim KW, Myers CJ, Jung DK and Lu B:
NVP-BEZ-235 enhances radiosensitization via blockade of the
PI3K/mTOR pathway in cisplatin-resistant non-small cell lung
carcinoma. Genes Cancer. 5:293–302. 2014.PubMed/NCBI
|
|
43
|
Pursiheimo JP, Rantanen K, Heikkinen PT,
Johansen T and Jaakkola PM: Hypoxia-activated autophagy accelerates
degradation of SQSTM1/p62. Oncogene. 28:334–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li X and Fan Z: The epidermal growth
factor receptor antibody cetuximab induces autophagy in cancer
cells by downregulating HIF-1alpha and Bcl-2 and activating the
beclin 1/hVps34 complex. Cancer Res. 70:5942–5952. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li YN, Hu JA and Wang HM: Inhibition of
HIF-1α affects autophagy mediated glycosylation in oral squamous
cell carcinoma cells. Dis Markers. 2015:2394792015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pouysségur J, Dayan F and Mazure NM:
Hypoxia signalling in cancer and approaches to enforce tumour
regression. Nature. 441:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bohensky J, Shapiro IM, Leshinsky S,
Terkhorn SP, Adams CS and Srinivas V: HIF-1 regulation of
chondrocyte apoptosis: Induction of the autophagic pathway.
Autophagy. 3:207–214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
He W, Wang Q, Xu J, Xu X, Padilla MT, Ren
G, Gou X and Lin Y: Attenuation of TNFSF10/TRAIL-induced apoptosis
by an autophagic survival pathway involving TRAF2- and
RIPK1/RIP1-mediated MAPK8/JNK activation. Autophagy. 8:1811–1821.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang W, Sun J and Luo J: High expression
of Rab-like 3 (Rabl3) is associated with poor survival of patients
with non-small cell lung cancer via repression of
MAPK8/9/10-mediated autophagy. Med Sci Monit. 22:1582–1588. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Nozawa T, Aikawa C, Goda A, Maruyama F,
Hamada S and Nakagawa I: The small GTPases Rab9A and Rab23 function
at distinct steps in autophagy during Group A Streptococcus
infection. Cell Microbiol. 14:1149–1165. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zheng LQ, Chi SM and Li CX: Rab23′s
genetic structure, function and related diseases: A review. Biosci
Rep. 37:BSR201604102017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang M, Dong Q and Wang Y: Rab23 is
overexpressed in human astrocytoma and promotes cell migration and
invasion through regulation of Rac1. Tumour Biol. 37:11049–11055.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Maiuri MC, Le Toumelin G, Criollo A, Rain
JC, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K,
Tavernarakis N, et al: Functional and physical interaction between
Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26:2527–2539.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Erlich S, Mizrachy L, Segev O, Lindenboim
L, Zmira O, Adi-Harel S, Hirsch JA, Stein R and Pinkas-Kramarski R:
Differential interactions between Beclin 1 and Bcl-2 family
members. Autophagy. 3:561–368. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yuan J, Zhang Y, Sheng Y, Fu X, Cheng H
and Zhou R: MYBL2 guides autophagy suppressor VDAC2 in the
developing ovary to inhibit autophagy through a complex of
VDAC2-BECN1-BCL2L1 in mammals. Autophagy. 11:1081–1098. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Maji S, Samal SK, Pattanaik L, Panda S,
Quinn BA, Das SK, Sarkar D, Pellecchia M, Fisher PB and Dash R:
Mcl-1 is an important therapeutic target for oral squamous cell
carcinomas. Oncotarget. 6:16623–16637. 2015. View Article : Google Scholar : PubMed/NCBI
|
